glp-1 agonists muscle loss does cause Weight loss and muscle building progress with GLP-1 GLP-1 side effect management: Preventing
Description
Lin LK, Sun Y, Heng BH, Chew DEK, Chong PN

Additionally, a doseresponse relationship has also been noted with specific agents
175 Mitochondrial dysfunction is a defect in the early stage of PD and mainly includes impairment of the mitochondrial electron transport chain, alterations in mitochondrial morphology and dynamics, mutations in mitochondrial DNA, and anomalies in calcium homeostasis, 176 which are closely related to the PD phenotype

Like liraglutide, gastrointestinal symptoms were the most common side effects, though generally well-tolerated
No individuals developed DKA

A key double-blind, placebo-controlled phase II study conducted over 72 weeks recruited 320 individuals with histologically confirmed NASH and liver fibrosis classified as stage F1 to F3